S
Sijin Wu
Researcher at Ohio State University
Publications - 34
Citations - 722
Sijin Wu is an academic researcher from Ohio State University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 11, co-authored 27 publications receiving 468 citations. Previous affiliations of Sijin Wu include Sun Yat-sen University & Dalian University of Technology.
Papers
More filters
Journal ArticleDOI
Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells
Bai Cui,Yuanyuan Luo,Pengfei Tian,Fei Peng,Jinxin Lu,Jinxin Lu,Yongliang Yang,Qitong Su,Bing Liu,Jiachuan Yu,Xi Luo,Liu Yin,Wei Cheng,Fan An,Bin He,Dapeng Liang,Sijin Wu,Peng Chu,Luyao Song,Xinyu Liu,Huandong Luo,Jie Xu,Yujia Pan,Yang Wang,Dangsheng Li,Peng Huang,Qingkai Yang,Lingqiang Zhang,Binhua P. Zhou,Suling Liu,Guowang Xu,Eric Lam,Keith W. Kelley,Quentin Liu,Quentin Liu +34 more
TL;DR: It is found that a chronic stress–induced cancer stem-like phenotype could be reversed by vitamin C, and the LDHA-lowering agent vitamin C can be a potential approach for combating stress-associated breast cancer.
Journal ArticleDOI
Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity and Special Mechanism *
Lin Wei,Jiuxiang Gao,Zhang Shumin,Sijin Wu,Xie Zeping,Ling Guiying,Yi-Qun Kuang,Yongliang Yang,Haining Yu,Yipeng Wang +9 more
TL;DR: This study demonstrates that Hc-CATH, the first cathelicidin from sea snake discovered to have both antimicrobial and anti-inflammatory activity, is a potent candidate for the development of peptide antibiotics.
Journal ArticleDOI
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
Zhi Jie Hou,Xi Luo,Wei Zhang,Fei Peng,Bai Cui,Sijin Wu,Fei Meng Zheng,Jie Xu,L. Xu,Zi Jie Long,Xue Ting Wang,Guohui Li,Xian Yao Wan,Yongliang Yang,Quentin Liu +14 more
TL;DR: A novel effect of flubendazole is demonstrated on suppressing breast CS-like cells and enhanced cytotoxic activity of conventional therapeutic drugs fluorouracil and doxorubicin against breast cancer cells.
Journal ArticleDOI
Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma
Haijun Wen,Haijun Wen,Huajuan Ma,Qichun Cai,Qichun Cai,Suxia Lin,Xinxing Lei,Bin He,Sijin Wu,Zifeng Wang,Yan Gao,Wensheng Liu,Weiping Liu,Qian Tao,Zijie Long,Min Yan,Dali Li,Keith W. Kelley,Yongliang Yang,Huiqiang Huang,Quentin Liu,Quentin Liu +21 more
TL;DR: Exome sequencing of ENKTL tumor–normal samples has identified a hotspot mutation in the evolutionarily conserved signaling intermediate in Toll pathway (ECSIT) gene, encoding a V140A variant of ECSIT, associated with activation of NF-κB, higher HPS incidence, and poor prognosis in individuals with ENkTL.
Journal ArticleDOI
CRM1 is a cellular target of curcumin: new insights for the myriad of biological effects of an ancient spice.
TL;DR: It is shown that CRM1, an important nuclear exportin, is a cellular target of curcumin by serious experimental and theoretical investigation, and computational modeling has revealed thatCurcumin could be correctly docked into the hydrophobic pocket ofCRM1 judged from shape complementarity and putative molecular interactions.